ESMO 2022 Conference Coverage


 

ESMO 2022 on DESTINY-Breast04 Patient-Reported Outcomes: T-DXd vs. TPC in HER2-Low mBC

480 views
October 3, 2022
Comments 0
Login to view comments. Click here to Login